$4.97
-0.29-5.42%
Last update: Nov 11, 2:50 PM
Exagen Inc (XGN) Stock Price, Quote, News & History
XGNNASDAQ
Exagen (NASDAQ:XGN) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.
Other companies in Exagen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Exagen has a consensus price target of $9.56.
The stock price for Exagen (NASDAQ: XGN) is $4.975 last updated November 11, 2026 at 2:50 PM EST.
There are no upcoming dividends for Exagen.
Exagen does not have any upcoming earnings scheduled.
There is no upcoming split for Exagen.
Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic,...
